Role of p38 mitogen-activated protein kinase in cardiac remodelling
- 29 January 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 150 (2), 130-135
- https://doi.org/10.1038/sj.bjp.0706963
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Mycobacterium tuberculosis Origin of Replication and the Promoter for Immunodominant Secreted Antigen 85B Are the Targets of MtrA, the Essential Response RegulatorPublished by Elsevier BV ,2010
- A Type Ib ParB Protein Involved in Plasmid Partitioning in a Gram-Positive BacteriumJournal of Bacteriology, 2006
- The Two-Component Regulatory System mtrAB Is Required for Morphotypic Multidrug Resistance in Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 2006
- Inhibition of p38 reduces myocardial infarction injury in the mouse but not pig after ischemia-reperfusionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Role of p38α MAPK in cardiac apoptosis and remodeling after myocardial infarctionJournal of Molecular and Cellular Cardiology, 2005
- p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the ratJournal of the American College of Cardiology, 2004
- WebLogo: A Sequence Logo Generator: Figure 1Genome Research, 2004
- Two-Component Signal TransductionAnnual Review of Biochemistry, 2000
- Characterization of the Mycobacterium tuberculosis iniBAC Promoter, a Promoter That Responds to Cell Wall Biosynthesis InhibitionJournal of Bacteriology, 2000
- Activation of c-Jun N-Terminal Kinases and p38-Mitogen-activated Protein Kinases in Human Heart Failure Secondary to Ischaemic Heart DiseaseJournal of Molecular and Cellular Cardiology, 1999